According to Abeona Therapeutics
's latest financial reports the company has $52.22 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $52.14 M | 15.82% |
2021-12-31 | $45.02 M | -52.62% |
2020-12-31 | $95.03 M | -26.48% |
2019-12-31 | $0.12 B | 52.13% |
2018-12-31 | $84.96 M | -38.32% |
2017-12-31 | $0.13 B | 99.23% |
2016-12-31 | $69.14 M | 72.26% |
2015-12-31 | $40.13 M | 248.42% |
2014-12-31 | $11.52 M | 2616.98% |
2013-12-31 | $0.42 M | 7.07% |
2012-12-31 | $0.39 M | -83.9% |
2011-12-31 | $2.46 M | -65.02% |
2010-12-31 | $7.03 M | 1058.65% |
2009-12-31 | $0.6 M | -77.33% |
2008-12-31 | $2.67 M | -61.32% |
2007-12-31 | $6.92 M | 57.69% |
2006-12-31 | $4.38 M | 825.95% |
2005-12-31 | $0.47 M | -79.04% |
2004-12-31 | $2.26 M | -12.6% |
2003-12-31 | $2.58 M | -73.54% |
2002-12-31 | $9.77 M | -51.43% |
2001-12-31 | $20.12 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Merck MRK | $7.09 B | 13,481.36% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $0.90 B | 1,627.52% | ๐ฎ๐ฑ Israel |